Related Experiment Video
Updated: Nov 29, 2025

Therapeutic Evaluation of Fecal Microbiota Transplantation in an Interleukin 10-Deficient Mouse Model
Published on: April 6, 2022
Intestinal microbiome: a new target for chalaziosis treatment in children?
Mariaelena Filippelli1, Roberto dell'Omo2, Angela Amoruso3
1Department of Medicine and Health Sciences "V. Tiberio", University of Molise, Campobasso, Molise, Italy. oftelena@gmail.com.
Insights
Oral probiotics significantly reduced chalazion resolution time in children. This gut microbiome modification offers a safe and effective adjunctive therapy for ophthalmic conditions like chalaziosis.
Area of Science:
- Ophthalmology
- Microbiology
- Immunology
Background:
- Intestinal dysbiosis is linked to various ophthalmic diseases.
- The gut microbiome is a recognized therapeutic target for inflammatory eye conditions.
- Probiotics are known for their role in pediatric health and disease prevention.
Purpose of the Study:
- To investigate the efficacy of oral probiotics in treating chalaziosis in children.
- To determine if specific probiotics can alter the clinical course and recurrence of chalaziosis.
- To assess the impact of probiotic supplementation on the resolution time of chalazion.
Main Methods:
- A prospective comparative pilot study involving 26 children with chalaziosis.
- Participants were randomized into two groups: medical treatment alone versus medical treatment plus oral probiotics.
- Probiotic group received a daily supplement containing Streptococcus thermophilus ST10, Lactococcus lactis LCC02, and Lactobacillus delbrueckii subsp. bulgaricus.
Main Results:
- A significant difference in the time to complete chalazion resolution was observed, favoring the probiotic group.
- Probiotic supplementation accelerated the resolution of chalazion compared to medical treatment alone.
- No significant complications were reported in either treatment group.
Conclusions:
- Modifying the intestinal microbiome with specific oral probiotics can positively impact chalaziosis in children.
- Probiotic supplementation enhances traditional therapies, leading to faster chalazion resolution.
- This approach offers a safe, feasible, and effective method to re-establish intestinal and immune homeostasis for ophthalmic health.
Abstract:
Intestinal dysbiosis (changes in the gut commensal microbiome) is related to several ophthalmic diseases. The aim of this study was to verify whether oral specific probiotics can alter the clinical course of chalaziosis and its recurrence. A prospective comparative pilot study involving 26 children suffering from chalaziosis was conducted. Children were randomly divided into two groups. The first group received medical treatment (lid hygiene, warm compression and dexamethasone/tobramycin ointment for at least 20 days), and the second group received medical treatment plus a daily supplementation of oral probiotics (≥ 1 × 10^9 live cells of Streptococcus thermophilus ST10 (DSM 25246), ≥ 1 × 10^9 live cells of Lactococcus lactis LCC02 (DSM 29536) and ≥ 1 × 10^9 live cells of Lactobacillus delbrueckii subsp. bulgaricus (DSM 16606) with maltodextrin as the bulking agent (Probiotical S.p.A., Novara, Italy). All patients were evaluated at 2-week intervals for 3 months. If the lesion had not disappeared or decreased in size to 1 mm or less in diameter at the time of subsequent visits, the same procedure was repeated for another 3-month cycle. There was a significant difference in the time taken for complete resolution of the chalazion between the two groups in favour of the children receiving the probiotics. The treatment was not associated with any significant complications in either group. Trial registration: The trial was registered at clinical trials.gov under NCT04322500 on 25/03/2020 ("retrospectively registered").Conclusions: Modification of the intestinal microbiome with specific probiotics can alter the clinical course of chalaziosis in children by re-establishing intestinal and immune homeostasis. Probiotic supplementation can increase the effectiveness of traditional therapies by prompting the complete resolution of chalaziosis in a shorter amount of time, in an easy and feasible way. What is Known: • The intestinal microbiome plays a crucial role in several inflammatory diseases of the eye and is considered a therapeutic target. • Probiotics play a role in the prevention and treatment of different conditions in children. What is New: • In children probiotic supplementation is safe and effective. • Probiotic supplementation reduced the time required for complete resolution of the chalazion.
More Related Videos
Related Concept Videos
Bacterial Phylum Chlamydiae
Fungal Phylum Microsporidia
Drugs Affecting GI Tract Motility: Antimicrobials as Antidiarrheal Agents

